Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Decompensation”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableLooking for participantsNCT06431919
What this trial is testing

Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival

Who this might be right for
Decompensated CirrhosisCirrhotic CardiomyopathyCirrhosis, Liver+2 more
Post Graduate Institute of Medical Education and Research, Chandigarh 260
Not applicableLooking for participantsNCT07291141
What this trial is testing

A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis

Who this might be right for
Liver CirrhosesHepatocellular Carcinoma (HCC)Sarcopenia in Liver Cirrhosis+3 more
Mattias Ekstedt 600
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05297448
What this trial is testing

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 466
Large-scale testing (Phase 3)Study completedNCT01157845
What this trial is testing

Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis

Who this might be right for
Cirrhosis
Virginia Commonwealth University 165
Not applicableStudy completedNCT05100485
What this trial is testing

Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)

Who this might be right for
Compensated Advanced Chronic Liver Disease
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000
Not applicableStudy completedNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,241
Not applicableStudy completedNCT02084160
What this trial is testing

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Who this might be right for
Chronic Liver Disease
Meridian Bioscience, Inc. 579
Not applicableStudy completedNCT01715779
What this trial is testing

Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies

Who this might be right for
Hepatitis C
Novartis 22
Not applicableEnded earlyNCT00375011
What this trial is testing

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Who this might be right for
Cirrhosis
Meridian Bioscience, Inc. 200
Early research (Phase 1)Study completedNCT03515980
What this trial is testing

An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function

Who this might be right for
Liver DysfunctionLiver InsufficiencyHepatic Failure+4 more
Bristol-Myers Squibb 76
Testing effectiveness (Phase 2)Ended earlyNCT06082843
What this trial is testing

Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly

Who this might be right for
Hypertension, PortalLiver Cirrhosis
Boehringer Ingelheim 22
Not applicableNot Yet RecruitingNCT07185360
What this trial is testing

Liver Diseases: Extracellular Vesicles as Biomarkers

Who this might be right for
Liver Diseases
Assistance Publique - Hôpitaux de Paris 845
Testing effectiveness (Phase 2)Ended earlyNCT06987968
What this trial is testing

See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute on Chronic Liver Failure (ACLF)Decompensated Cirrhosis
Genfit 3
Not applicableUnknownNCT04460157
What this trial is testing

Prediction of Liver-related Outcomes After HCV Cure

Who this might be right for
Hepatitis C, ChronicSustained Virological ResponseDirect-acting Antivirals+2 more
Hospital Universitario de Valme 1,035
Large-scale testing (Phase 3)Active Not RecruitingNCT05071716
What this trial is testing

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 524
Post-approval studies (Phase 4)Looking for participantsNCT06449339
What this trial is testing

Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease

Who this might be right for
Portal HypertensionHepatic DecompensationAdvanced Chronic Liver Disease
Chinese University of Hong Kong 474
Testing effectiveness (Phase 2)Ended earlyNCT05900050
What this trial is testing

Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®

Who this might be right for
Acute-On-Chronic Liver FailureAscites
Genfit 15
Not applicableLooking for participantsNCT06432582
What this trial is testing

HepatomiR cACLD Study

Who this might be right for
Chronic Liver Disease and CirrhosisChronic Liver DiseasePortal Hypertension
Karl Landsteiner University of Health Sciences 156
Post-approval studies (Phase 4)Study completedNCT01059396
What this trial is testing

Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal

Who this might be right for
Portal Hypertension GastropathyEsophageal VaricesSpontaneous Bacterial Peritonitis+2 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 201
Load More Results